Weighted Average Number of Shares Outstanding, Diluted of TENAX THERAPEUTICS, INC. from 31 Jul 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
TENAX THERAPEUTICS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Jul 2010 to 31 Dec 2025.
  • TENAX THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 39,217,244, a 157% increase year-over-year.
  • TENAX THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 39,217,244, a 157% increase from 2024.
  • TENAX THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 15,271,705, a 6047% increase from 2023.
  • TENAX THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 248,447.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

TENAX THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 39,217,244 +23,945,539 +157% 01 Oct 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 39,741,404 +18,580,261 +88% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 39,572,177 +37,613,932 +1921% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 36,584,920 +35,365,781 +2901% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 15,271,705 01 Oct 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 21,161,143 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 1,958,245 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 1,219,139 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2015 28,077,963 +18,715,932 +200% 01 Feb 2015 30 Apr 2015 10-KT 14 Mar 2016 2015 FY
Q4 2014 28,119,360 +17,852,759 +174% 01 Nov 2014 31 Jan 2015 10-Q 17 Mar 2015 2015 Q3
Q3 2014 28,107,395 +23,158,453 +468% 01 Aug 2014 31 Oct 2014 10-Q 15 Dec 2014 2015 Q2
Q2 2014 27,661,499 +25,451,248 +1152% 01 May 2014 31 Jul 2014 10-Q 15 Sep 2014 2015 Q1
Q1 2014 9,362,031 +7,603,006 +432% 01 Feb 2014 30 Apr 2014 10-KT 14 Mar 2016 2015 FY
Q4 2013 10,266,601 +8,498,961 +481% 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2015 2015 Q3
Q3 2013 4,948,942 +3,236,487 +189% 01 Aug 2013 31 Oct 2013 10-Q 15 Dec 2014 2015 Q2
Q2 2013 2,210,251 +592,145 +37% 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014 2015 Q1
Q1 2013 1,759,025 +371,404 +27% 01 Feb 2013 30 Apr 2013 10-KT 14 Mar 2016 2015 FY
Q4 2012 1,767,640 -27,963,841 -94% 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014 2014 Q3
Q3 2012 1,712,455 -24,267,759 -93% 01 Aug 2012 31 Oct 2012 10-Q 17 Dec 2013 2014 Q2
Q2 2012 1,618,106 -22,525,891 -93% 01 May 2012 31 Jul 2012 10-Q 17 Sep 2013 2014 Q1
Q1 2012 1,387,621 -21,958,875 -94% 01 Feb 2012 30 Apr 2012 10-K 26 Jun 2013 2013 FY
Q4 2011 29,731,481 +6,340,326 +27% 01 Nov 2011 31 Jan 2012 10-Q 18 Mar 2013 2013 Q3
Q3 2011 25,980,214 +2,592,235 +11% 01 Aug 2011 31 Oct 2011 10-Q 14 Dec 2012 2013 Q2
Q2 2011 24,143,997 +928,289 +4% 01 May 2011 31 Jul 2011 10-Q 19 Sep 2012 2013 Q1
Q1 2011 23,346,496 01 Feb 2011 30 Apr 2011 10-K 25 Jul 2012 2012 FY
Q4 2010 23,391,155 01 Nov 2010 31 Jan 2011 10-Q 15 Mar 2012 2012 Q3
Q3 2010 23,387,979 01 Aug 2010 31 Oct 2010 10-Q 15 Dec 2011 2012 Q2
Q2 2010 23,215,708 01 May 2010 31 Jul 2010 10-Q 19 Sep 2011 2012 Q1

TENAX THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 39,217,244 +23,945,539 +157% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 15,271,705 +15,023,258 +6047% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 248,447 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2014 28,077,963 +18,715,932 +200% 01 May 2014 30 Apr 2015 10-KT 14 Mar 2016 2015 FY
2013 9,362,031 +7,603,006 +432% 01 May 2013 30 Apr 2014 10-KT 14 Mar 2016 2015 FY
2012 1,759,025 +371,404 +27% 01 May 2012 30 Apr 2013 10-KT 14 Mar 2016 2015 FY
2011 1,387,621 -21,958,875 -94% 01 May 2011 30 Apr 2012 10-K 26 Jun 2013 2013 FY
2010 23,346,496 01 May 2010 30 Apr 2011 10-K 25 Jul 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.